Samsung Electronics subsidiary NeuroLogica announced today that it received FDA 510(k) clearance for new technology on its OmniTom Elite. Danvers, Massachusetts–based NeuroLogica’s OmniTom Elite computed tomography (CT) scanner now has single-source photon-counting detector (PCD) technology, allowing it to generate spectral CT images at multiple energy levels. NeuroLogica said in a news release that its platform […]
Samsung Electronics (LON:BC94) subsidiary NeuroLogica said today that it inked a distribution deal with MaxQ AI to integrate its artificial intelligence software with NeuroLogica’s medical imaging tech in the U.S. and EU’s acute care marketplace. Through the deal, NeuroLogica said that it will offer MaxQ’s Accipio IX, part of the AI-company’s FDA-cleared and CE Mark approved […]
Samsung Electronics (LON:BC94) subsidiary NeuroLogica won a $250 million maximum firm-fixed-price contract to supply the US Dept. of Defense with radiology systems, accessories and training, according to a newly posted release. The contract for the Danvers, Mass.-based subsidiary is located in Massachusetts and has a five-year base and an additional five-year option period, according to the […]
Samsung Electronics (LON:BC94) subsidiary NeuroLogica said yesterday it won FDA 510(k) clearance for its GC85A digital radiography system. The newly cleared ceiling x-ray unit comes with S-Vue imaging, a wireless S-Detector, mobile system control, smart stiching and other improvements, the company said. “The Samsung GC85A represents NeuroLogica’s latest commitment to introducing user and patient-centric innovation […]
The U.S. Department of Defense awarded Danvers, Mass.-based device company NeuroLogica Corp. another year and a maximum of $12 million in a fixed-price radiological devices contract that may last as many as 7 years.
The Philadelphia, Pa.-based troop support division of the DoD contracted NeuroLogica for the 3rd extension of a contract that can be renewed a maximum of 4 more times.
Venture-backed M&A activity in 2011 was higher than any other year since 2005, according to a new report tracking trends in lifesciences.
The medical device industry in 2011 had 18 "Big Exits," defined as venture-backed acquisitions where the up-front payment totaled $75 million or more.